ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-4R430
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Drugs Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Oncology Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-4R430
Report
July 2025
Pages:173
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Astrazeneca plc
Sanofi
Novartis
Celgene
Bristol–Myers Squibb
Johnson & Johnson
Merck
Pfizer Inc
Amgen Inc
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen S A
Bayer
Biogen Idec
TEVA
Otsuka
Eisai Co Ltd
Merck KGaA
Gilead Sciences

Oncology Drugs Market Size

In 2024, the global market size of Oncology Drugs was estimated to be worth US$ 239850 million and is forecast to reach approximately US$ 471950 million by 2031 with a CAGR of 10.3% during the forecast period 2025-2031.

Oncology Drugs Market

Oncology Drugs Market

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
The industry"s leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Drugs.
The Oncology Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Oncology Drugs Market Report

Report Metric Details
Report Name Oncology Drugs Market
CAGR 10.3%
Segment by Type
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Others
Segment by Application
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory or Lung Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Oncology Drugs in global and regional level.
  • Chapter 3: Detailed analysis of Oncology Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Drugs revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Roche, Celgene, Novartis share in Oncology Drugs Market?

Ans: The industry"s leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues.

What is the Oncology Drugs Market share by region?

Ans: By region, North America had the highest share of income, at 43%.

Who are the main players in the Oncology Drugs Market report?

Ans: The main players in the Oncology Drugs Market are Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences

What are the Application segmentation covered in the Oncology Drugs Market report?

Ans: The Applications covered in the Oncology Drugs Market report are Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory or Lung Cancer, Others

What are the Type segmentation covered in the Oncology Drugs Market report?

Ans: The Types covered in the Oncology Drugs Market report are Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, Others

1 Study Coverage
1.1 Oncology Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Drugs Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Drugs Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oncology Drugs Market Size Estimates and Forecasts
2.2 Oncology Drugs Market Size by Region: 2024 Versus 2031
2.2.1 Global Oncology Drugs Revenue by Region: 2020-2025
2.2.2 Global Oncology Drugs Revenue Forecast by Region (2026-2031)
2.2.3 Global Oncology Drugs Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Oncology Drugs Revenue by Type (2020-2031)
3.1.2 Global Oncology Drugs Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Oncology Drugs Revenue by Application (2020-2031)
3.2.2 Global Oncology Drugs Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Chemotherapy of Oncology Drugs Revenue Market Share by Application
3.3.2 Targeted Therapy of Oncology Drugs Revenue Market Share by Application
3.3.3 Immunotherapy (Biologic Therapy) of Oncology Drugs Revenue Market Share by Application
3.3.4 Hormonal Therapy of Oncology Drugs Revenue Market Share by Application
3.3.5 Others of Oncology Drugs Revenue Market Share by Application
4 Global Oncology Drugs by Company
4.1 Global Oncology Drugs Revenue by Company (2020-2025)
4.2 Global Oncology Drugs Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Oncology Drugs Companies around the World: Ranking by Revenue
4.3.2 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Oncology Drugs Companies Headquarters & Product Type
4.4.1 Global Oncology Drugs Companies Headquarters
4.4.2 Date of International Companies Enter into Oncology Drugs Market
4.4.3 Global Oncology Drugs Companies Product & Service
4.4.4 Chemotherapy Revenue Market Share of Oncology Drugs by Company
4.4.5 Targeted Therapy Revenue Market Share of Oncology Drugs by Company
4.4.6 Immunotherapy (Biologic Therapy) Revenue Market Share of Oncology Drugs by Company
4.4.7 Hormonal Therapy Revenue Market Share of Oncology Drugs by Company
4.4.8 Others Revenue Market Share of Oncology Drugs by Company
4.5 Global Oncology Drugs Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Corporation Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche Oncology Drugs Products Offered
5.1.4 Roche Oncology Drugs Revenue and Gross Margin (2020-2025)
5.1.5 Roche Oncology Drugs Revenue by Product in 2024
5.1.6 Roche Oncology Drugs Revenue by Application in 2024
5.1.7 Roche Oncology Drugs Revenue by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 Celgene
5.2.1 Celgene Corporation Information
5.2.2 Celgene Description, Business Overview
5.2.3 Celgene Oncology Drugs Products Offered
5.2.4 Celgene Oncology Drugs Revenue and Gross Margin (2020-2025)
5.2.5 Celgene Oncology Drugs Revenue by Product in 2024
5.2.6 Celgene Oncology Drugs Revenue by Application in 2024
5.2.7 Celgene Oncology Drugs Revenue by Geographic Area in 2024
5.2.8 Celgene Recent Developments
5.3 Novartis
5.3.1 Novartis Corporation Information
5.3.2 Novartis Description, Business Overview
5.3.3 Novartis Oncology Drugs Products Offered
5.3.4 Novartis Oncology Drugs Revenue and Gross Margin (2020-2025)
5.3.5 Novartis Oncology Drugs Revenue by Product in 2024
5.3.6 Novartis Oncology Drugs Revenue by Application in 2024
5.3.7 Novartis Oncology Drugs Revenue by Geographic Area in 2024
5.3.8 Novartis Recent Developments
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Corporation Information
5.4.2 Bristol-Myers Squibb Description, Business Overview
5.4.3 Bristol-Myers Squibb Oncology Drugs Products Offered
5.4.4 Bristol-Myers Squibb Oncology Drugs Revenue and Gross Margin (2020-2025)
5.4.5 Bristol-Myers Squibb Oncology Drugs Revenue by Product in 2024
5.4.6 Bristol-Myers Squibb Oncology Drugs Revenue by Application in 2024
5.4.7 Bristol-Myers Squibb Oncology Drugs Revenue by Geographic Area in 2024
5.4.8 Bristol-Myers Squibb Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Corporation Information
5.5.2 Johnson & Johnson Description, Business Overview
5.5.3 Johnson & Johnson Oncology Drugs Products Offered
5.5.4 Johnson & Johnson Oncology Drugs Revenue and Gross Margin (2020-2025)
5.5.5 Johnson & Johnson Oncology Drugs Revenue by Product in 2024
5.5.6 Johnson & Johnson Oncology Drugs Revenue by Application in 2024
5.5.7 Johnson & Johnson Oncology Drugs Revenue by Geographic Area in 2024
5.5.8 Johnson & Johnson Recent Developments
5.6 Merck & Co.
5.6.1 Merck & Co. Corporation Information
5.6.2 Merck & Co. Description, Business Overview
5.6.3 Merck & Co. Oncology Drugs Products Offered
5.6.4 Merck & Co. Oncology Drugs Revenue and Gross Margin (2020-2025)
5.6.5 Merck & Co. Oncology Drugs Revenue by Product in 2024
5.6.6 Merck & Co. Oncology Drugs Revenue by Application in 2024
5.6.7 Merck & Co. Oncology Drugs Revenue by Geographic Area in 2024
5.6.8 Merck & Co. Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Corporation Information
5.7.2 AstraZeneca Description, Business Overview
5.7.3 AstraZeneca Oncology Drugs Products Offered
5.7.4 AstraZeneca Oncology Drugs Revenue and Gross Margin (2020-2025)
5.7.5 AstraZeneca Oncology Drugs Revenue by Product in 2024
5.7.6 AstraZeneca Oncology Drugs Revenue by Application in 2024
5.7.7 AstraZeneca Oncology Drugs Revenue by Geographic Area in 2024
5.7.8 AstraZeneca Recent Developments
5.8 Pfizer
5.8.1 Pfizer Corporation Information
5.8.2 Pfizer Description, Business Overview
5.8.3 Pfizer Oncology Drugs Products Offered
5.8.4 Pfizer Oncology Drugs Revenue and Gross Margin (2020-2025)
5.8.5 Pfizer Oncology Drugs Revenue by Product in 2024
5.8.6 Pfizer Oncology Drugs Revenue by Application in 2024
5.8.7 Pfizer Oncology Drugs Revenue by Geographic Area in 2024
5.8.8 Pfizer Recent Developments
5.9 Amgen
5.9.1 Amgen Corporation Information
5.9.2 Amgen Description, Business Overview
5.9.3 Amgen Oncology Drugs Products Offered
5.9.4 Amgen Oncology Drugs Revenue and Gross Margin (2020-2025)
5.9.5 Amgen Oncology Drugs Revenue by Product in 2024
5.9.6 Amgen Oncology Drugs Revenue by Application in 2024
5.9.7 Amgen Oncology Drugs Revenue by Geographic Area in 2024
5.9.8 Amgen Recent Developments
5.10 Eli Lilly
5.10.1 Eli Lilly Corporation Information
5.10.2 Eli Lilly Description, Business Overview
5.10.3 Eli Lilly Oncology Drugs Products Offered
5.10.4 Eli Lilly Oncology Drugs Revenue and Gross Margin (2020-2025)
5.10.5 Eli Lilly Oncology Drugs Revenue by Product in 2024
5.10.6 Eli Lilly Oncology Drugs Revenue by Application in 2024
5.10.7 Eli Lilly Oncology Drugs Revenue by Geographic Area in 2024
5.10.8 Eli Lilly Recent Developments
5.11 AbbVie
5.11.1 AbbVie Corporation Information
5.11.2 AbbVie Description, Business Overview
5.11.3 AbbVie Oncology Drugs Products Offered
5.11.4 AbbVie Oncology Drugs Revenue and Gross Margin (2020-2025)
5.11.5 AbbVie Oncology Drugs Revenue by Product in 2024
5.11.6 AbbVie Oncology Drugs Revenue by Application in 2024
5.11.7 AbbVie Oncology Drugs Revenue by Geographic Area in 2024
5.11.8 AbbVie Recent Developments
5.12 Takeda
5.12.1 Takeda Corporation Information
5.12.2 Takeda Description, Business Overview
5.12.3 Takeda Oncology Drugs Products Offered
5.12.4 Takeda Oncology Drugs Revenue and Gross Margin (2020-2025)
5.12.5 Takeda Oncology Drugs Revenue by Product in 2024
5.12.6 Takeda Oncology Drugs Revenue by Application in 2024
5.12.7 Takeda Oncology Drugs Revenue by Geographic Area in 2024
5.12.8 Takeda Recent Developments
5.13 Astellas
5.13.1 Astellas Corporation Information
5.13.2 Astellas Description, Business Overview
5.13.3 Astellas Oncology Drugs Products Offered
5.13.4 Astellas Oncology Drugs Revenue and Gross Margin (2020-2025)
5.13.5 Astellas Oncology Drugs Revenue by Product in 2024
5.13.6 Astellas Oncology Drugs Revenue by Application in 2024
5.13.7 Astellas Oncology Drugs Revenue by Geographic Area in 2024
5.13.8 Astellas Recent Developments
5.14 Ipsen
5.14.1 Ipsen Corporation Information
5.14.2 Ipsen Description, Business Overview
5.14.3 Ipsen Oncology Drugs Products Offered
5.14.4 Ipsen Oncology Drugs Revenue and Gross Margin (2020-2025)
5.14.5 Ipsen Oncology Drugs Revenue by Product in 2024
5.14.6 Ipsen Oncology Drugs Revenue by Application in 2024
5.14.7 Ipsen Oncology Drugs Revenue by Geographic Area in 2024
5.14.8 Ipsen Recent Developments
5.15 Sanofi
5.15.1 Sanofi Corporation Information
5.15.2 Sanofi Description, Business Overview
5.15.3 Sanofi Oncology Drugs Products Offered
5.15.4 Sanofi Oncology Drugs Revenue and Gross Margin (2020-2025)
5.15.5 Sanofi Oncology Drugs Revenue by Product in 2024
5.15.6 Sanofi Oncology Drugs Revenue by Application in 2024
5.15.7 Sanofi Oncology Drugs Revenue by Geographic Area in 2024
5.15.8 Sanofi Recent Developments
5.16 Bayer
5.16.1 Bayer Corporation Information
5.16.2 Bayer Description, Business Overview
5.16.3 Bayer Oncology Drugs Products Offered
5.16.4 Bayer Oncology Drugs Revenue and Gross Margin (2020-2025)
5.16.5 Bayer Oncology Drugs Revenue by Product in 2024
5.16.6 Bayer Oncology Drugs Revenue by Application in 2024
5.16.7 Bayer Oncology Drugs Revenue by Geographic Area in 2024
5.16.8 Bayer Recent Developments
5.17 Biogen Idec
5.17.1 Biogen Idec Corporation Information
5.17.2 Biogen Idec Description, Business Overview
5.17.3 Biogen Idec Oncology Drugs Products Offered
5.17.4 Biogen Idec Oncology Drugs Revenue and Gross Margin (2020-2025)
5.17.5 Biogen Idec Oncology Drugs Revenue by Product in 2024
5.17.6 Biogen Idec Oncology Drugs Revenue by Application in 2024
5.17.7 Biogen Idec Oncology Drugs Revenue by Geographic Area in 2024
5.17.8 Biogen Idec Recent Developments
5.18 Teva
5.18.1 Teva Corporation Information
5.18.2 Teva Description, Business Overview
5.18.3 Teva Oncology Drugs Products Offered
5.18.4 Teva Oncology Drugs Revenue and Gross Margin (2020-2025)
5.18.5 Teva Oncology Drugs Revenue by Product in 2024
5.18.6 Teva Oncology Drugs Revenue by Application in 2024
5.18.7 Teva Oncology Drugs Revenue by Geographic Area in 2024
5.18.8 Teva Recent Developments
5.19 Otsuka
5.19.1 Otsuka Corporation Information
5.19.2 Otsuka Description, Business Overview
5.19.3 Otsuka Oncology Drugs Products Offered
5.19.4 Otsuka Oncology Drugs Revenue and Gross Margin (2020-2025)
5.19.5 Otsuka Oncology Drugs Revenue by Product in 2024
5.19.6 Otsuka Oncology Drugs Revenue by Application in 2024
5.19.7 Otsuka Oncology Drugs Revenue by Geographic Area in 2024
5.19.8 Otsuka Recent Developments
5.20 Eisai
5.20.1 Eisai Corporation Information
5.20.2 Eisai Description, Business Overview
5.20.3 Eisai Oncology Drugs Products Offered
5.20.4 Eisai Oncology Drugs Revenue and Gross Margin (2020-2025)
5.20.5 Eisai Oncology Drugs Revenue by Product in 2024
5.20.6 Eisai Oncology Drugs Revenue by Application in 2024
5.20.7 Eisai Oncology Drugs Revenue by Geographic Area in 2024
5.20.8 Eisai Recent Developments
5.21 Merck KGaA
5.21.1 Merck KGaA Corporation Information
5.21.2 Merck KGaA Description, Business Overview
5.21.3 Merck KGaA Oncology Drugs Products Offered
5.21.4 Merck KGaA Oncology Drugs Revenue and Gross Margin (2020-2025)
5.21.5 Merck KGaA Oncology Drugs Revenue by Product in 2024
5.21.6 Merck KGaA Oncology Drugs Revenue by Application in 2024
5.21.7 Merck KGaA Oncology Drugs Revenue by Geographic Area in 2024
5.21.8 Merck KGaA Recent Developments
5.22 Gilead Sciences
5.22.1 Gilead Sciences Corporation Information
5.22.2 Gilead Sciences Description, Business Overview
5.22.3 Gilead Sciences Oncology Drugs Products Offered
5.22.4 Gilead Sciences Oncology Drugs Revenue and Gross Margin (2020-2025)
5.22.5 Gilead Sciences Oncology Drugs Revenue by Product in 2024
5.22.6 Gilead Sciences Oncology Drugs Revenue by Application in 2024
5.22.7 Gilead Sciences Oncology Drugs Revenue by Geographic Area in 2024
5.22.8 Gilead Sciences Recent Developments
6 North America
6.1 North America Oncology Drugs Market Size YoY Growth 2020-2031
6.2 North America Oncology Drugs Market Facts & Figures by Country (2020-2031)
6.3 North America Oncology Drugs Revenue by Type (2020-2025)
6.4 North America Oncology Drugs Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Oncology Drugs Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Oncology Drugs Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Oncology Drugs Revenue by Type (2020-2025)
7.4 Asia-Pacific Oncology Drugs Revenue by Application (2020-2025)
8 Europe
8.1 Europe Oncology Drugs Market Size YoY Growth 2020-2031
8.2 Europe Oncology Drugs Market Facts & Figures by Country (2020-2031)
8.3 Europe Oncology Drugs Revenue by Type (2020-2025)
8.4 Europe Oncology Drugs Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Oncology Drugs Market Size YoY Growth 2020-2031
9.2 Latin America Oncology Drugs Market Facts & Figures by Country (2020-2031)
9.3 Latin America Oncology Drugs Revenue by Type (2020-2025)
9.4 Latin America Oncology Drugs Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Oncology Drugs Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Oncology Drugs Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Oncology Drugs Revenue by Type (2020-2025)
10.4 Middle East and Africa Oncology Drugs Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Oncology Drugs Supply Chain Analysis
11.2 Oncology Drugs Key Raw Materials and Upstream Suppliers
11.3 Oncology Drugs Clients Analysis
11.4 Oncology Drugs Sales Channel and Sales Model Analysis
11.4.1 Oncology Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Oncology Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Oncology Drugs Distributors
12 Oncology Drugs Market Dynamics
12.1 Oncology Drugs Industry Trends
12.2 Oncology Drugs Market Drivers
12.3 Oncology Drugs Market Challenges
12.4 Oncology Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Roche
Astrazeneca plc
Sanofi
Novartis
Celgene
Bristol–Myers Squibb
Johnson & Johnson
Merck
Pfizer Inc
Amgen Inc
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen S A
Bayer
Biogen Idec
TEVA
Otsuka
Eisai Co Ltd
Merck KGaA
Gilead Sciences
List of Tables
 Table 1. Global Oncology Drugs Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Oncology Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Oncology Drugs Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Oncology Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Oncology Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Oncology Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Oncology Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Oncology Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Oncology Drugs Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Oncology Drugs Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Oncology Drugs Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Oncology Drugs Players by Revenue (US$ Million) in 2024
 Table 13. Global Oncology Drugs Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drugs as of 2024)
 Table 15. Global Oncology Drugs Companies Headquarters
 Table 16. Date of International Companies Enter into Oncology Drugs Market
 Table 17. Global Oncology Drugs Companies Product & Service
 Table 18. Global Oncology Drugs Mergers & Acquisitions, Expansion Plans
 Table 19. Roche Corporation Information
 Table 20. Roche Description and Business Overview
 Table 21. Roche Oncology Drugs Product
 Table 22. Roche Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Roche Revenue Proportion of Oncology Drugs by Product in 2024
 Table 24. Roche Revenue Proportion of Oncology Drugs by Application in 2024
 Table 25. Roche Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 26. Roche Recent Developments
 Table 27. Celgene Corporation Information
 Table 28. Celgene Description and Business Overview
 Table 29. Celgene Oncology Drugs Product
 Table 30. Celgene Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Celgene Revenue Proportion of Oncology Drugs by Product in 2024
 Table 32. Celgene Revenue Proportion of Oncology Drugs by Application in 2024
 Table 33. Celgene Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 34. Celgene Recent Developments
 Table 35. Novartis Corporation Information
 Table 36. Novartis Description and Business Overview
 Table 37. Novartis Oncology Drugs Product
 Table 38. Novartis Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Novartis Revenue Proportion of Oncology Drugs by Product in 2024
 Table 40. Novartis Revenue Proportion of Oncology Drugs by Application in 2024
 Table 41. Novartis Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 42. Novartis Recent Developments
 Table 43. Bristol-Myers Squibb Corporation Information
 Table 44. Bristol-Myers Squibb Description and Business Overview
 Table 45. Bristol-Myers Squibb Oncology Drugs Product
 Table 46. Bristol-Myers Squibb Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Bristol-Myers Squibb Revenue Proportion of Oncology Drugs by Product in 2024
 Table 48. Bristol-Myers Squibb Revenue Proportion of Oncology Drugs by Application in 2024
 Table 49. Bristol-Myers Squibb Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 50. Bristol-Myers Squibb Recent Developments
 Table 51. Johnson & Johnson Corporation Information
 Table 52. Johnson & Johnson Description and Business Overview
 Table 53. Johnson & Johnson Oncology Drugs Product
 Table 54. Johnson & Johnson Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Johnson & Johnson Revenue Proportion of Oncology Drugs by Product in 2024
 Table 56. Johnson & Johnson Revenue Proportion of Oncology Drugs by Application in 2024
 Table 57. Johnson & Johnson Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 58. Johnson & Johnson Recent Developments
 Table 59. Merck & Co. Corporation Information
 Table 60. Merck & Co. Description and Business Overview
 Table 61. Merck & Co. Oncology Drugs Product
 Table 62. Merck & Co. Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Merck & Co. Revenue Proportion of Oncology Drugs by Product in 2024
 Table 64. Merck & Co. Revenue Proportion of Oncology Drugs by Application in 2024
 Table 65. Merck & Co. Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 66. Merck & Co. Recent Developments
 Table 67. AstraZeneca Corporation Information
 Table 68. AstraZeneca Description and Business Overview
 Table 69. AstraZeneca Oncology Drugs Product
 Table 70. AstraZeneca Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. AstraZeneca Revenue Proportion of Oncology Drugs by Product in 2024
 Table 72. AstraZeneca Revenue Proportion of Oncology Drugs by Application in 2024
 Table 73. AstraZeneca Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 74. AstraZeneca Recent Developments
 Table 75. Pfizer Corporation Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Oncology Drugs Product
 Table 78. Pfizer Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Pfizer Revenue Proportion of Oncology Drugs by Product in 2024
 Table 80. Pfizer Revenue Proportion of Oncology Drugs by Application in 2024
 Table 81. Pfizer Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 82. Pfizer Recent Developments
 Table 83. Amgen Corporation Information
 Table 84. Amgen Description and Business Overview
 Table 85. Amgen Oncology Drugs Product
 Table 86. Amgen Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Amgen Revenue Proportion of Oncology Drugs by Product in 2024
 Table 88. Amgen Revenue Proportion of Oncology Drugs by Application in 2024
 Table 89. Amgen Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 90. Amgen Recent Developments
 Table 91. Eli Lilly Corporation Information
 Table 92. Eli Lilly Description and Business Overview
 Table 93. Eli Lilly Oncology Drugs Product
 Table 94. Eli Lilly Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Eli Lilly Revenue Proportion of Oncology Drugs by Product in 2024
 Table 96. Eli Lilly Revenue Proportion of Oncology Drugs by Application in 2024
 Table 97. Eli Lilly Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 98. Eli Lilly Recent Developments
 Table 99. AbbVie Corporation Information
 Table 100. AbbVie Description and Business Overview
 Table 101. AbbVie Oncology Drugs Product
 Table 102. AbbVie Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. AbbVie Revenue Proportion of Oncology Drugs by Product in 2024
 Table 104. AbbVie Revenue Proportion of Oncology Drugs by Application in 2024
 Table 105. AbbVie Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 106. AbbVie Recent Developments
 Table 107. Takeda Corporation Information
 Table 108. Takeda Description and Business Overview
 Table 109. Takeda Oncology Drugs Product
 Table 110. Takeda Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Takeda Revenue Proportion of Oncology Drugs by Product in 2024
 Table 112. Takeda Revenue Proportion of Oncology Drugs by Application in 2024
 Table 113. Takeda Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 114. Takeda Recent Developments
 Table 115. Astellas Corporation Information
 Table 116. Astellas Description and Business Overview
 Table 117. Astellas Oncology Drugs Product
 Table 118. Astellas Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Astellas Revenue Proportion of Oncology Drugs by Product in 2024
 Table 120. Astellas Revenue Proportion of Oncology Drugs by Application in 2024
 Table 121. Astellas Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 122. Astellas Recent Developments
 Table 123. Ipsen Corporation Information
 Table 124. Ipsen Description and Business Overview
 Table 125. Ipsen Oncology Drugs Product
 Table 126. Ipsen Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. Ipsen Revenue Proportion of Oncology Drugs by Product in 2024
 Table 128. Ipsen Revenue Proportion of Oncology Drugs by Application in 2024
 Table 129. Ipsen Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 130. Ipsen Recent Developments
 Table 131. Sanofi Corporation Information
 Table 132. Sanofi Description and Business Overview
 Table 133. Sanofi Oncology Drugs Product
 Table 134. Sanofi Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 135. Sanofi Revenue Proportion of Oncology Drugs by Product in 2024
 Table 136. Sanofi Revenue Proportion of Oncology Drugs by Application in 2024
 Table 137. Sanofi Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 138. Sanofi Recent Developments
 Table 139. Bayer Corporation Information
 Table 140. Bayer Description and Business Overview
 Table 141. Bayer Oncology Drugs Product
 Table 142. Bayer Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Bayer Revenue Proportion of Oncology Drugs by Product in 2024
 Table 144. Bayer Revenue Proportion of Oncology Drugs by Application in 2024
 Table 145. Bayer Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 146. Bayer Recent Developments
 Table 147. Biogen Idec Corporation Information
 Table 148. Biogen Idec Description and Business Overview
 Table 149. Biogen Idec Oncology Drugs Product
 Table 150. Biogen Idec Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 151. Biogen Idec Revenue Proportion of Oncology Drugs by Product in 2024
 Table 152. Biogen Idec Revenue Proportion of Oncology Drugs by Application in 2024
 Table 153. Biogen Idec Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 154. Biogen Idec Recent Developments
 Table 155. Teva Corporation Information
 Table 156. Teva Description and Business Overview
 Table 157. Teva Oncology Drugs Product
 Table 158. Teva Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 159. Teva Revenue Proportion of Oncology Drugs by Product in 2024
 Table 160. Teva Revenue Proportion of Oncology Drugs by Application in 2024
 Table 161. Teva Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 162. Teva Recent Developments
 Table 163. Otsuka Corporation Information
 Table 164. Otsuka Description and Business Overview
 Table 165. Otsuka Oncology Drugs Product
 Table 166. Otsuka Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 167. Otsuka Revenue Proportion of Oncology Drugs by Product in 2024
 Table 168. Otsuka Revenue Proportion of Oncology Drugs by Application in 2024
 Table 169. Otsuka Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 170. Otsuka Recent Developments
 Table 171. Eisai Corporation Information
 Table 172. Eisai Description and Business Overview
 Table 173. Eisai Oncology Drugs Product
 Table 174. Eisai Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 175. Eisai Revenue Proportion of Oncology Drugs by Product in 2024
 Table 176. Eisai Revenue Proportion of Oncology Drugs by Application in 2024
 Table 177. Eisai Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 178. Eisai Recent Developments
 Table 179. Merck KGaA Corporation Information
 Table 180. Merck KGaA Description and Business Overview
 Table 181. Merck KGaA Oncology Drugs Product
 Table 182. Merck KGaA Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 183. Merck KGaA Revenue Proportion of Oncology Drugs by Product in 2024
 Table 184. Merck KGaA Revenue Proportion of Oncology Drugs by Application in 2024
 Table 185. Merck KGaA Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 186. Merck KGaA Recent Developments
 Table 187. Gilead Sciences Corporation Information
 Table 188. Gilead Sciences Description and Business Overview
 Table 189. Gilead Sciences Oncology Drugs Product
 Table 190. Gilead Sciences Oncology Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 191. Gilead Sciences Revenue Proportion of Oncology Drugs by Product in 2024
 Table 192. Gilead Sciences Revenue Proportion of Oncology Drugs by Application in 2024
 Table 193. Gilead Sciences Revenue Proportion of Oncology Drugs by Geographic Area in 2024
 Table 194. Gilead Sciences Recent Developments
 Table 195. North America Oncology Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 196. North America Oncology Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 197. North America Oncology Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 198. North America Oncology Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 199. Asia-Pacific Oncology Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 200. Asia-Pacific Oncology Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 201. Asia-Pacific Oncology Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 202. Asia-Pacific Oncology Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 203. Europe Oncology Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 204. Europe Oncology Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 205. Europe Oncology Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 206. Europe Oncology Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 207. Latin America Oncology Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 208. Latin America Oncology Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 209. Latin America Oncology Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 210. Latin America Oncology Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 211. Middle East and Africa Oncology Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 212. Middle East and Africa Oncology Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 213. Middle East and Africa Oncology Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 214. Middle East and Africa Oncology Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 215. Oncology Drugs Key Raw Materials, Industry Status and Trend
 Table 216. Oncology Drugs Key Raw Materials and Upstream Suppliers
 Table 217. Oncology Drugs Clients Status and Trend
 Table 218. Oncology Drugs Typical Clients
 Table 219. Oncology Drugs Distributors
 Table 220. Oncology Drugs Market Trends
 Table 221. Oncology Drugs Market Drivers
 Table 222. Oncology Drugs Market Challenges
 Table 223. Oncology Drugs Market Restraints
 Table 224. Research Programs/Design for This Report
 Table 225. Key Data Information from Secondary Sources
 Table 226. Key Data Information from Primary Sources


List of Figures
 Figure 1. Oncology Drugs Product Picture
 Figure 2. Global Oncology Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Oncology Drugs Revenue Market Share by Type in 2024 & 2031
 Figure 4. Chemotherapy Product Picture
 Figure 5. Targeted Therapy Product Picture
 Figure 6. Immunotherapy (Biologic Therapy) Product Picture
 Figure 7. Hormonal Therapy Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Oncology Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 10. Global Oncology Drugs Revenue Market Share by Application in 2024 & 2031
 Figure 11. Blood Cancer
 Figure 12. Breast Cancer
 Figure 13. Gastrointestinal Cancer
 Figure 14. Prostate Cancer
 Figure 15. Respiratory or Lung Cancer
 Figure 16. Others
 Figure 17. Oncology Drugs Report Years Considered
 Figure 18. Global Oncology Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Oncology Drugs Market Size (2020-2031) & (US$ Million)
 Figure 20. Global Oncology Drugs Market Size Market Share by Region: 2024 Versus 2031
 Figure 21. Global Oncology Drugs Revenue Market Share by Region (2020-2031)
 Figure 22. Global Oncology Drugs Revenue Market Share Forecast by Type (2020-2031)
 Figure 23. Global Oncology Drugs Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Chemotherapy of Oncology Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Targeted Therapy of Oncology Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Immunotherapy (Biologic Therapy) of Oncology Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Hormonal Therapy of Oncology Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Others of Oncology Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Oncology Drugs Revenue Share by Company (2024)
 Figure 30. Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 31. Chemotherapy Revenue Proportion by Company in 2024
 Figure 32. Targeted Therapy Revenue Proportion by Company in 2024
 Figure 33. Immunotherapy (Biologic Therapy) Revenue Proportion by Company in 2024
 Figure 34. Hormonal Therapy Revenue Proportion by Company in 2024
 Figure 35. Others Revenue Proportion by Company in 2024
 Figure 36. North America Oncology Drugs Revenue 2020-2031 (US$ Million)
 Figure 37. North America Oncology Drugs Revenue Market Share by Type (2020-2025)
 Figure 38. North America Oncology Drugs Revenue Market Share by Application (2020-2025)
 Figure 39. Asia-Pacific Oncology Drugs Revenue 2020-2031 (US$ Million)
 Figure 40. Asia-Pacific Oncology Drugs Revenue Market Share by Region (2020-2031)
 Figure 41. Asia-Pacific Oncology Drugs Revenue Market Share by Type (2020-2025)
 Figure 42. Asia-Pacific Oncology Drugs Revenue Market Share by Application (2020-2025)
 Figure 43. Europe Oncology Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 44. Europe Oncology Drugs Revenue Market Share by Country (2020-2031)
 Figure 45. Europe Oncology Drugs Revenue Market Share by Type (2020-2025)
 Figure 46. Europe Oncology Drugs Revenue Market Share by Application (2020-2025)
 Figure 47. Latin America Oncology Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Latin America Oncology Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Latin America Oncology Drugs Revenue Market Share by Type (2020-2025)
 Figure 50. Latin America Oncology Drugs Revenue Market Share by Application (2020-2025)
 Figure 51. Middle East and Africa Oncology Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 52. Middle East and Africa Oncology Drugs Revenue Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Oncology Drugs Revenue Market Share by Type (2020-2025)
 Figure 54. Middle East and Africa Oncology Drugs Revenue Market Share by Application (2020-2025)
 Figure 55. Oncology Drugs Supply Chain (Upstream and Downstream Market)
 Figure 56. Global Production Market Share of Oncology Drugs Raw Materials by Region in 2024
 Figure 57. Oncology Drugs Distribution Channels
 Figure 58. Global Oncology Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 59. Global Oncology Drugs Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Drugs for Oncology Market Insights Forecast to 2030
Global Oncology Therapeutic Drug Market Research Report 2024
Oncology Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tumor Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Separation and Characterization in Solid Tumors Market Insights Forecast to 2030
Global Solid Tumor Therapeutics Market Research Report 2024
Global Brain Cancer Targeted Drug Market Research Report 2025
Global Brain Tumor Therapeutics Market Research Report 2024
Global Targeted Therapy for Brain Cancer Market Research Report 2025
Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030
Global Breast Cancer Targeted Drug Market Research Report 2025
Global Rectal Cancer Therapeutics Market Insights Forecast to 2030
Global Oncology Small Molecule Drugs Market Insights Forecast to 2030
Global Tumor Genomics Market Research Report 2024
Global Targeted Therapy for Breast Cancer Market Research Report 2025
Global Prostate Cancer Market Insights Forecast to 2030
Global Breast Cancer Drugs Market Insights Forecast to 2030
Global Brain and Central Nervous System Cancer Treatments Market Research Report 2024
Global Bone Tumor Ablation Devices Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions